• Our Mission
    • Overview
    • Leadership
  • Science & Technology
    • CoreX™
    • AlloChem™
    • Mine™
  • Pipeline
  • Investors
    • Overview
    • Press Releases
    • Events & Presentations
    • SEDAR+ Filings
    • Stock Information
    • Leadership
    • Investor FAQ
    • Email Alerts

Sharp Therapeutics Corp. Announces Completion of Qualifying Transaction

Dec 12, 2024 | Press Releases

Toronto, Ontario–(December 12, 2024) – Sharp Therapeutics Corp. (TSXV: EVP.P) (“Sharp Therapeutics”), formerly EVP Capital Inc. (“EVP Capital”), an Ontario corporation is pleased to announce the successful completion of its...
Next Entries »

Recent Posts

  • Sharp Therapeutics Corp. Reports First Half 2026 Results and Development Update
  • Sharp Therapeutics Announces Closing of Non-Brokered Private Placement
  • Sharp Therapeutics Corp. Announces Results from Annual Meeting of Shareholders
  • Sharp Therapeutics Announces Non-Brokered Private Placement and Provides Operational Update
  • Sharp Therapeutics Announces Filing of Amended and Restated Management Information Circular and New Annual Meeting Date

Recent Comments

No comments to show.

Stay connected

  • Our Mission
    • Overview
    • Leadership
  • Science & Technology
    • CoreX™
    • AlloChem™
    • Mine™
  • Pipeline
  • Investors
    • Overview
    • Press Releases
    • Events & Presentations
    • SEDAR+ Filings
    • Stock Information
    • Leadership
    • Investor FAQ
    • Email Alerts
  • Follow
  • Follow
  • Follow

© Sharp Therapeutics Corp. All Rights Reserved.